LINC00942 accelerates esophageal cancer progression via NAT10/HSPD1
Cellular Signalling · 2026
DOI: 10.1016/j.cellsig.2026.112393 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026. Verfasst von Luoshai Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Huai'an Hospital of Huai'an City (Huai'an Cancer Hospital), Huai'an 223200, Jiangsu, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Esophageal Neoplasms, N-Terminal Acetyltransferase E. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Jiangsu Commission of Health.
Abstract (Originalsprache)
Long non-coding RNAs (lncRNAs) have been implicated in the progression of esophageal cancer (ESCA). This study investigates the oncogenic role of LINC00942 in ESCA, revealing its upregulation in tumor tissues and cell lines. Functional assays demonstrated that suppression of LINC00942 significantly reduced cell viability and tumor growth while promoting apoptosis both in vitro and in vivo using a xenograft tumor model. Mechanistically, LINC00942 silencing decreased NAT10 expression in ESCA cells and tumors, with NAT10 overexpression rescuing the inhibition of ESCA cell proliferation, migration, and invasion induced by LINC00942 knockdown, alongside a reduction in apoptosis and tumor growth inhibition. Notably, LINC00942 directly interacted with NAT10, which were co-localized in the nucleus. Further analysis indicated that NAT10 overexpression enhanced the stability and expression of HSPD1 through increased N4-acetylcytidine (ac4C) modification, thereby exerting its effects by interacting with HSPD1. These findings highlight the pivotal role of the LINC00942/NAT10/HSPD1 axis in ESCA development, suggesting it as a potential biomarker and therapeutic target for the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Huai'an Hospital of Huai'an City (Huai'an Cancer Hospital), Huai'an 223200, Jiangsu, China.
- Department of Oncology, Huai'an Hospital of Huai'an City (Huai'an Cancer Hospital), Huai'an 223200, Jiangsu, China.
- Department of Oncology, Huai'an Hospital of Huai'an City (Huai'an Cancer Hospital), Huai'an 223200, Jiangsu, China. Electronic address: yaojuandoctor@163.com.
- Department of Thoracic Surgery, Jiangsu Cancer Hospital & The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Institute of Cancer Research, Nanjing 210009, Jiangsu, China. Electronic address: wangzhon…
Förderung
- Jiangsu Commission of Health
Zitieren
APA
Wang, L., Ge, R., Li, H., Yang, J., Yao, J., & Wang, Z. (2026). LINC00942 accelerates esophageal cancer progression via NAT10/HSPD1. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2026.112393
Vancouver
Wang L, Ge R, Li H, Yang J, Yao J, Wang Z. LINC00942 accelerates esophageal cancer progression via NAT10/HSPD1. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2026.112393
BibTeX
@article{Wang2026,
author = {Wang, Luoshai and Ge, Rongrong and Li, Hang and Yang, Jiazhi and Yao, Juan and Wang, Zhongqiu},
title = {LINC00942 accelerates esophageal cancer progression via NAT10/HSPD1},
journal = {Cellular Signalling},
year = {2026},
doi = {10.1016/j.cellsig.2026.112393}
}
EUVIMED